"Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes." New England Journal of Medicine , vol
That's the difference between a laboratory curiosity and a compound with genuine research potential
in people age 75 to 84, the annual incidence was 3.2% (32 of every 1,000 people)
Recalls & Warnings July 26, 2013 Safety of Certain Weight Loss and Bodybuilding Supplements Called Into Question On July 25, 2013, USA Today reported that several supplements, including weight loss, body building and sports nutrition supplements, have come under scrutiny after being found to contain illegal ingredients, or were associated with failed drug tests and adverse events
No clinical claims or therapeutic uses are implied
Biophys Chem 267:106492